Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Acquisition of Zevacor Pharma Complete, Rebranding as Sofie

By Sofie | September 28, 2017

Sofie Biosciences, Inc., the molecular imaging company specializing in novel tools for PET imaging and radiosynthesis of PET compounds, has announced the completion of the acquisition of Zevacor Pharma to form “Sofie.” 

The addition of Zevacor Pharma’s 16 radiopharmacies and contract manufacturing organization will complement Sofie Biosciences’ imaging and radiochemistry product lines, bringing innovative technologies and theranostic production together under one company focused on the growth of molecular imaging and radioisotope-based therapeutics for clinical and preclinical use.

Zevacor Pharma, formerly known as IBA North America, annually serves over 425,000 patients and 700+ clinical practices. Patrick Phelps, President and CEO of SOFIE remarked: “As SOFIE, we’ll continue Zevacor Pharma’s commitment to customers, while making significant improvements to prepare us for growth as we help bring about the next generation of theranostics and tools to make and use them.” 

A management team that includes Chief Revenue Officer Philipp Czernin, Chief Financial Officer Stan Berman, and Chief Technology Officer Melissa Moore will support Phelps. 

Philipp Czernin, heading business development for the combined company, commented: “We’re looking to invest and improve the capabilities of the 16 sites to scale production of FDG and new products like Neuraceq for positron emitting tomography (PET) imaging of patients being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment, Netspot for localization of somatostatin receptor positive neuroendocrine tumors (NETs) using PET, 11C-Choline PET scans in those patients with biochemical failure from prostate cancer and negative anatomical imaging to restage the patient, and NaF PET scans for detection and evaluation of bone metastases.” 

Melissa Moore, who will oversee operations for the commercial radiopharmacy and contract manufacturing organization, said: “With this acquisition, SOFIE will support the efforts of our academic and Pharma partners to help bring their novel diagnostics and therapeutics from early R&D through clinical trials and—hopefully—into routine clinical production. This is an amazing opportunity for us and our field.”

(Source: PR Newswire)

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE